157 related articles for article (PubMed ID: 11170505)
21. 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants.
Monks TJ; Highet RJ; Lau SS
Mol Pharmacol; 1988 Oct; 34(4):492-500. PubMed ID: 3173333
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of 2-(glutathion-S-yl)hydroquinone and 2,3,5- (triglutathion-S-yl)hydroquinone in the in situ perfused rat kidney: relationship to nephrotoxicity.
Hill BA; Davison KL; Dulik DM; Monks TJ; Lau SS
Toxicol Appl Pharmacol; 1994 Nov; 129(1):121-32. PubMed ID: 7974485
[TBL] [Abstract][Full Text] [Related]
23. 2,3,5-tris(Glutathion-S-yl)hydroquinone (TGHQ)-mediated apoptosis of human promyelocytic leukemia cells is preceded by mitochondrial cytochrome c release in the absence of a decrease in the mitochondrial membrane potential.
Yang MY; Lau SS; Monks TJ
Toxicol Sci; 2005 Jul; 86(1):92-100. PubMed ID: 15800030
[TBL] [Abstract][Full Text] [Related]
24. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.
Toyokuni S; Okada K; Kondo S; Nishioka H; Tanaka T; Nishiyama Y; Hino O; Hiai H
Jpn J Cancer Res; 1998 Aug; 89(8):814-20. PubMed ID: 9765616
[TBL] [Abstract][Full Text] [Related]
25. Cell-specific regulation of Nrf2 during ROS-Dependent cell death caused by 2,3,5-tris(glutathion-S-yl)hydroquinone (TGHQ).
Zhang F; Munoz FM; Sun L; Zhang S; Lau SS; Monks TJ
Chem Biol Interact; 2019 Apr; 302():1-10. PubMed ID: 30703377
[TBL] [Abstract][Full Text] [Related]
26. Differential regulation of redox responsive transcription factors by the nephrocarcinogen 2,3,5-Tris(glutathion-S-yl)hydroquinone.
Weber TJ; Huang Q; Monks TJ; Lau SS
Chem Res Toxicol; 2001 Jul; 14(7):814-21. PubMed ID: 11453727
[TBL] [Abstract][Full Text] [Related]
27. Use of the spontaneous Tsc2 knockout (Eker) rat model of hereditary renal cell carcinoma for the study of renal carcinogens.
McDorman KS; Wolf DC
Toxicol Pathol; 2002; 30(6):675-80. PubMed ID: 12512868
[TBL] [Abstract][Full Text] [Related]
28. Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment.
Shibata MA; Hirose M; Tanaka H; Asakawa E; Shirai T; Ito N
Jpn J Cancer Res; 1991 Nov; 82(11):1211-9. PubMed ID: 1752780
[TBL] [Abstract][Full Text] [Related]
29. Presence of a modifier gene(s) affecting early renal carcinogenesis in the Tsc2 mutant (Eker) rat model.
Kikuchi Y; Sudo A; Mitani H; Hino O
Int J Oncol; 2004 Jan; 24(1):75-80. PubMed ID: 14654943
[TBL] [Abstract][Full Text] [Related]
30. Metabolism and toxicity of 2-bromo-(diglutathion-S-yl)-hydroquinone and 2-bromo-3-(glutathion-S-yl)hydroquinone in the in situ perfused rat kidney.
Rivera MI; Hinojosa LM; Hill BA; Lau SS; Monks TJ
Drug Metab Dispos; 1994; 22(4):503-10. PubMed ID: 7956722
[TBL] [Abstract][Full Text] [Related]
31. Estrogen treatment enhances hereditary renal tumor development in Eker rats.
Wolf DC; Goldsworthy TL; Donner EM; Harden R; Fitzpatrick B; Everitt JI
Carcinogenesis; 1998 Nov; 19(11):2043-7. PubMed ID: 9855022
[TBL] [Abstract][Full Text] [Related]
32. Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.
Jeong JK; Stevens JL; Lau SS; Monks TJ
Mol Pharmacol; 1996 Sep; 50(3):592-8. PubMed ID: 8794898
[TBL] [Abstract][Full Text] [Related]
33. The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis.
Zhang F; Lau SS; Monks TJ
Toxicol Sci; 2011 Mar; 120(1):87-97. PubMed ID: 21135414
[TBL] [Abstract][Full Text] [Related]
34. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.
Urakami S; Tokuzen R; Tsuda H; Igawa M; Hino O
J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374
[TBL] [Abstract][Full Text] [Related]
35. PARP-1 hyperactivation and reciprocal elevations in intracellular Ca2+ during ROS-induced nonapoptotic cell death.
Zhang F; Xie R; Munoz FM; Lau SS; Monks TJ
Toxicol Sci; 2014 Jul; 140(1):118-34. PubMed ID: 24752504
[TBL] [Abstract][Full Text] [Related]
36. Specific induction of hepatocellular adenomas by transplacental administration of ENU in the tsc2 gene mutant (Eker) rat.
Fukuda T; Mitani H; Tsutsumi M; Konishi Y; Hino O
Int J Oncol; 1998 Nov; 13(5):957-61. PubMed ID: 9772285
[TBL] [Abstract][Full Text] [Related]
37. Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.
Lau SS; Kleiner HE; Monks TJ
Drug Metab Dispos; 1995 Oct; 23(10):1136-42. PubMed ID: 8654203
[TBL] [Abstract][Full Text] [Related]
38. Grp78 is essential for 11-deoxy-16,16-dimethyl PGE2-mediated cytoprotection in renal epithelial cells.
Jia Z; Person MD; Dong J; Shen J; Hensley SC; Stevens JL; Monks TJ; Lau SS
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1113-22. PubMed ID: 15226156
[TBL] [Abstract][Full Text] [Related]
39. Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butyl-hydroxyanisole, are toxic to kidney and bladder.
Peters MM; Rivera MI; Jones TW; Monks TJ; Lau SS
Cancer Res; 1996 Mar; 56(5):1006-11. PubMed ID: 8640754
[TBL] [Abstract][Full Text] [Related]
40. Increased susceptibility to in vitro transformation of cells carrying the Eker tumor susceptibility mutation.
Horesovsky G; Ginsler J; Everitt J; Walker C
Carcinogenesis; 1994 Oct; 15(10):2183-7. PubMed ID: 7955051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
